LBX Pharmacy Chain Joint Stock Company

Shanghai Stock Exchange 603883.SS

LBX Pharmacy Chain Joint Stock Company EBITDA for the year ending December 31, 2023: USD 411.01 M

LBX Pharmacy Chain Joint Stock Company EBITDA is USD 411.01 M for the year ending December 31, 2023, a 2.18% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

LBX Pharmacy Chain Joint Stock Company EBITDA for the year ending December 31, 2022 was USD 402.25 M, a 7.40% change year over year.
LBX Pharmacy Chain Joint Stock Company EBITDA for the year ending December 31, 2021 was USD 374.54 M, a 91.30% change year over year.
LBX Pharmacy Chain Joint Stock Company EBITDA for the year ending December 31, 2020 was USD 195.78 M, a 30.63% change year over year.
LBX Pharmacy Chain Joint Stock Company EBITDA for the year ending December 31, 2019 was USD 149.87 M, a 11.85% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Shanghai Stock Exchange: 603883.SS

LBX Pharmacy Chain Joint Stock Company

CEO	Mr. Xin Wan
IPO Date	April 23, 2015
Location	China
Headquarters	No. 1 (Xingsha) Kaiyuanxi Road
Employees	40,881
Sector	Health Care
Industries Drugstores & Retail Pharmacies Pharmaceuticals

Description

LBX Pharmacy Chain Joint Stock Company operates pharmacy store chain in China. The company operates stores in 21 provincial markets, including Hunan, Jiangsu, Gansu, Shaanxi, Guangxi, Anhui, Zhejiang, Inner Mongolia, Hubei, Tianjin, Henan, Shanghai, Shandong, Guangdong, Hebei, Beijing, Jiangxi, Ningxia, Sichuan, Fujian, and Guizhou. The company was formerly known as Laobaixing Pharmacy Chain Joint Stock Company. LBX Pharmacy Chain Joint Stock Company was founded in 2001 and is based in Changsha, China.

Key trends

Past 5 years